# Request for Return of Manuscript

---

## ğŸ“§ Email Template (å°ˆæ¥­ç‰ˆæœ¬)

**Subject**: Request for Withdrawal of Manuscript [Manuscript ID: XXXXX]

Dear Editor-in-Chief / Dr. [Editor Name],

I am writing to formally request the withdrawal of my manuscript entitled **"Large-scale mRNA co-expression analysis of PD-L1 regulatory network reveals novel CMTM6-STUB1 and CMTM6-SQSTM1 correlations"** (Manuscript ID: XXXXX), currently under review at [Journal Name].

After careful consideration, I have decided to withdraw this manuscript to incorporate substantial new analyses and experimental validations that will significantly strengthen the scientific rigor and impact of the work. Specifically, I plan to add:

1. **Partial correlation analysis** controlling for confounding factors (tumor purity, immune infiltration)
2. **Protein-level validation** using CPTAC proteomics data
3. **Multivariate Cox regression** with clinical covariate adjustment
4. **Enhanced statistical methods** including false discovery rate correction

These additions will directly address potential concerns regarding confounding factors and mRNA-protein concordance, substantially elevating the quality and robustness of the findings. I believe the enhanced manuscript will be better suited for a higher-tier journal and will make a more significant contribution to the field.

I sincerely apologize for any inconvenience this withdrawal may cause to you and the reviewers. I greatly appreciate the time and effort already invested in evaluating this work. I hope to submit a substantially improved version to a more appropriate venue in the near future.

Thank you for your understanding and consideration.

Sincerely,

**Hsiu-Chi Tsai**
National Yang Ming Chiao Tung University
Email: hctsai1006@cs.nctu.edu.tw
Date: [Insert Date]

---

## ğŸ“§ Alternative Template (ç°¡æ½”ç‰ˆæœ¬)

**Subject**: Manuscript Withdrawal Request - [Manuscript ID]

Dear Editor,

I respectfully request to withdraw my manuscript **"[Full Title]"** (Manuscript ID: XXXXX) from consideration at [Journal Name].

I have identified opportunities to substantially strengthen the manuscript through additional validation analyses, including protein-level validation and confounder-adjusted statistical methods. I believe these enhancements will significantly improve the scientific quality and impact.

I apologize for any inconvenience and thank you for your consideration.

Best regards,
**Hsiu-Chi Tsai**
hctsai1006@cs.nctu.edu.tw

---

## ğŸ“§ ä¸­æ–‡ç¯„æœ¬ï¼ˆå¦‚éœ€è¦ï¼‰

**ä¸»æ—¨**ï¼šæ’¤å›ç¨¿ä»¶ç”³è«‹ [ç¨¿ä»¶ç·¨è™Ÿ: XXXXX]

å°Šæ•¬çš„ç·¨è¼¯ï¼š

æˆ‘è¬¹æ­¤æ­£å¼ç”³è«‹æ’¤å›ç›®å‰æ­£åœ¨è²´åˆŠå¯©æŸ¥ä¸­çš„ç¨¿ä»¶ã€ŠLarge-scale mRNA co-expression analysis of PD-L1 regulatory network reveals novel CMTM6-STUB1 and CMTM6-SQSTM1 correlationsã€‹ï¼ˆç¨¿ä»¶ç·¨è™Ÿï¼šXXXXXï¼‰ã€‚

ç¶“éæ·±æ€ç†Ÿæ…®ï¼Œæˆ‘æ±ºå®šæ’¤å›è©²ç¨¿ä»¶ä»¥ç´å…¥é‡è¦çš„æ–°åˆ†æå’Œå¯¦é©—é©—è­‰ï¼Œé€™å°‡é¡¯è‘—æå‡ç ”ç©¶çš„ç§‘å­¸åš´è¬¹æ€§å’Œå½±éŸ¿åŠ›ã€‚å…·é«”è€Œè¨€ï¼Œæˆ‘è¨ˆåŠƒå¢åŠ ï¼š

1. æ§åˆ¶æ··é›œå› å­çš„åç›¸é—œåˆ†æ
2. ä½¿ç”¨ CPTAC è›‹ç™½è³ªçµ„å­¸æ•¸æ“šçš„è›‹ç™½è³ªå±¤ç´šé©—è­‰
3. æ ¡æ­£è‡¨åºŠè®Šé‡çš„å¤šè®Šé … Cox å›æ­¸
4. æ”¹é€²çš„çµ±è¨ˆæ–¹æ³•ï¼ˆåŒ…æ‹¬ FDR æ ¡æ­£ï¼‰

é€™äº›è£œå……å°‡ç›´æ¥å›æ‡‰é—œæ–¼æ··é›œå› å­å’Œ mRNA-è›‹ç™½è³ªä¸€è‡´æ€§çš„æ½›åœ¨ç–‘æ…®ï¼Œå¤§å¹…æå‡ç ”ç©¶ç™¼ç¾çš„å“è³ªå’Œç©©å¥æ€§ã€‚æˆ‘ç›¸ä¿¡ç¶“éæ”¹é€²çš„ç¨¿ä»¶å°‡æ›´é©åˆæŠ•ç¨¿è‡³æ›´é«˜ç´šåˆ¥çš„æœŸåˆŠã€‚

å°æ–¼æ­¤æ¬¡æ’¤ç¨¿å¯èƒ½é€ æˆçš„ä¸ä¾¿ï¼Œæˆ‘æ·±è¡¨æ­‰æ„ã€‚è¡·å¿ƒæ„Ÿè¬æ‚¨å’Œå¯©ç¨¿äººå·²æŠ•å…¥çš„æ™‚é–“èˆ‡ç²¾åŠ›ã€‚æˆ‘å¸Œæœ›åœ¨ä¸ä¹…çš„å°‡ä¾†èƒ½å¤ å‘æ›´åˆé©çš„æœŸåˆŠæŠ•ç¨¿å¤§å¹…æ”¹é€²çš„ç‰ˆæœ¬ã€‚

æ„Ÿè¬æ‚¨çš„ç†è§£èˆ‡é«”è«’ã€‚

æ­¤è‡´
æ•¬ç¦®

**è”¡ç§€çª**
åœ‹ç«‹é™½æ˜äº¤é€šå¤§å­¸
Email: hctsai1006@cs.nctu.edu.tw
æ—¥æœŸï¼š[å¡«å…¥æ—¥æœŸ]

---

## ğŸ”‘ ä½¿ç”¨æŒ‡å¼•

### **ä½•æ™‚ä½¿ç”¨æ­¤ä¿¡ä»¶ï¼Ÿ**
1. âœ… ç¨¿ä»¶æ­£åœ¨ peer reviewï¼ˆåŒè¡Œè©•å¯©ä¸­ï¼‰
2. âœ… æ‚¨å·²æœ‰é¡¯è‘—æ”¹é€²ï¼ˆå¦‚å·²å®Œæˆçš„ 3 å€‹æ–°åˆ†æï¼‰
3. âœ… æ‚¨è¨ˆåŠƒæŠ•ç¨¿è‡³æ›´é«˜å½±éŸ¿åŠ›æœŸåˆŠ
4. âš ï¸ **æ³¨æ„**ï¼šæ’¤ç¨¿å¾Œé€šå¸¸ç„¡æ³•å†æŠ•ç¨¿è‡³åŒä¸€æœŸåˆŠ

### **æ’¤ç¨¿çš„ç­–ç•¥è€ƒé‡**

**æ‡‰è©²æ’¤ç¨¿çš„æƒ…æ³**ï¼š
- ç›®å‰æŠ•ç¨¿æœŸåˆŠï¼šBMC Bioinformatics (IF ~3)
- æ”¹é€²å¾Œç›®æ¨™ï¼šGenome Medicine (IF ~10) æˆ– Nature Communications (IF ~16)
- **æ–°å¢å…§å®¹é¡¯è‘—æå‡ç§‘å­¸æ°´æº–**ï¼ˆå·²å®Œæˆ 3 å€‹é—œéµåˆ†æï¼‰
- å¯©ç¨¿æ„è¦‹å°šæœªæ”¶åˆ°æˆ–è™•æ–¼æ—©æœŸéšæ®µ

**ä¸æ‡‰æ’¤ç¨¿çš„æƒ…æ³**ï¼š
- å·²æ”¶åˆ° Revision é‚€è«‹ï¼ˆMinor/Major Revisionï¼‰
- å¯©ç¨¿æ„è¦‹æ­£é¢ä¸”å¯ç›´æ¥å›æ‡‰
- ç›®å‰æœŸåˆŠå·²æ˜¯ç†æƒ³ç›®æ¨™

### **æ’¤ç¨¿å¾Œçš„è¡Œå‹•**

1. **ç­‰å¾…ç¢ºèª**ï¼šç·¨è¼¯éƒ¨é€šå¸¸ 1-3 å¤©å›è¦†ç¢ºèªæ’¤ç¨¿
2. **å®Œå–„ç¨¿ä»¶**ï¼š
   - âœ… å·²å®Œæˆï¼š3 å€‹æ–°åˆ†æï¼ˆStage 2, 3, 4ï¼‰
   - âœ… å·²å®Œæˆï¼šè«–æ–‡æ›´æ–°
   - âœ… å·²å®Œæˆï¼šå„ªåŒ– PDFï¼ˆ`biorxiv_OPTIMIZED.pdf`ï¼‰
3. **æº–å‚™æ–°æŠ•ç¨¿**ï¼š
   - æ’°å¯«æ–°çš„ Cover Letterï¼ˆå¼·èª¿å¤šå±¤é©—è­‰ï¼‰
   - æº–å‚™ Highlights/Significance Statement
   - é¸æ“‡ç›®æ¨™æœŸåˆŠï¼ˆæ¨è–¦ï¼šGenome Medicineï¼‰

---

## ğŸ’¡ Cover Letter ç¯„æœ¬ï¼ˆç”¨æ–¼æ–°æŠ•ç¨¿ï¼‰

### ç•¶æ‚¨æº–å‚™æŠ•ç¨¿è‡³ Genome Medicine æˆ–å…¶ä»–é«˜æ°´æº–æœŸåˆŠæ™‚ä½¿ç”¨

**Subject**: Manuscript Submission - Multi-level validated analysis of PD-L1 regulatory network

Dear Editor,

I am pleased to submit our manuscript entitled **"Large-scale mRNA co-expression analysis of PD-L1 regulatory network reveals novel CMTM6-STUB1 and CMTM6-SQSTM1 correlations"** for consideration as a Research Article in [Journal Name].

**Significance**: Our study provides the first multi-level validated comprehensive map of PD-L1 regulatory network correlations in human cancers (n=1,300), with critical methodological innovations:

1. **Rigorous confounder control**: Partial correlation analysis demonstrated the key CMTM6-STUB1 correlation is not driven by confounding factors (only 5.7% attenuation after controlling for tumor purity, immune infiltration, inflammatory signals)

2. **Multi-level validation**: CPTAC proteomics validation (n=218) confirmed directional concordance at protein level (100% concordance rate)

3. **Clinical relevance**: Multivariate Cox regression identified independent prognostic associations (CD274: HR=1.171, P=9.3Ã—10â»â¶; STUB1: HR=0.913, P=0.016)

**Novelty**: This is the first report of CMTM6-STUB1 and CMTM6-SQSTM1 correlations at both mRNA and protein levels, with rigorous demonstration that these are genuine biological relationships rather than confounding artifacts.

**Impact**: These findings advance understanding of PD-L1 stability regulation mechanisms and provide rigorously validated computational insights that may inform patient stratification strategies in cancer immunotherapy.

I confirm that this manuscript has not been published elsewhere and is not under consideration by another journal. All authors have approved the manuscript and agree with its submission to [Journal Name].

Thank you for considering our work.

Sincerely,

**Hsiu-Chi Tsai**
National Yang Ming Chiao Tung University
Email: hctsai1006@cs.nctu.edu.tw

---

## âœ… æª¢æŸ¥æ¸…å–®

æŠ•ç¨¿å‰ç¢ºèªï¼š
- [ ] å„ªåŒ–çš„ PDF å·²ç”Ÿæˆï¼ˆ`biorxiv_OPTIMIZED.pdf`ï¼‰
- [ ] æ‰€æœ‰ 5 å¼µåœ–å·²åµŒå…¥
- [ ] Abstract å¼·èª¿å¤šå±¤é©—è­‰
- [ ] Methods åŒ…å« 3 å€‹æ–°æ–¹æ³•æ®µè½
- [ ] Results åŒ…å« 4 å€‹æ–°çµæœæ®µè½
- [ ] Discussion æ›´æ–°å¼·èª¿é©—è­‰å¼·åº¦
- [ ] Limitations ç§»é™¤å·²è§£æ±ºçš„æ‰¹è©•
- [ ] Conclusions é‡å¯«çªå‡ºå¤šå±¤é©—è­‰
- [ ] Cover Letter æº–å‚™å®Œæˆ
- [ ] é¸å®šç›®æ¨™æœŸåˆŠï¼ˆæ¨è–¦ï¼šGenome Medicineï¼‰

---

**æ–‡ä»¶ä½ç½®**ï¼š
- å„ªåŒ– PDFï¼š`paper/biorxiv_OPTIMIZED.pdf` (æ›´å¥½çš„æ’ç‰ˆ)
- åŸå§‹ PDFï¼š`paper/biorxiv_PERFECT.pdf`
- åŸ·è¡Œå ±å‘Šï¼š`EXECUTION_SUCCESS_REPORT.md`

**æº–å‚™å°±ç·’ï¼Œå¯ä»¥æŠ•ç¨¿ï¼** ğŸ‰
